X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome ...
Moderna secures EU COVID-19 vaccine supply deal
CAMBRIDGE, MA - Moderna , Inc. (NASDAQ:MRNA) has secured a tender to supply its mRNA COVID-19 vaccine to the European Union, including additional countries Norway and North Macedonia. The agreement, ...